Trial · NCT02105974
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 2 Week Run-in Period | STARTED | Placebo Run-In | 2,423 | |
| 2 Week Run-in Period | STARTED | FF/VI 100/25 µg QD | 0 | |
| 2 Week Run-in Period | STARTED | VI 25 µg QD | 0 | |
| 2 Week Run-in Period | COMPLETED | Placebo Run-In | 1,622 | |
| 2 Week Run-in Period | COMPLETED | FF/VI 100/25 µg QD | 0 | |
| 2 Week Run-in Period | COMPLETED | VI 25 µg QD | 0 | |
| 2 Week Run-in Period | NOT COMPLETED | Placebo Run-In | 801 | |
| 2 Week Run-in Period | NOT COMPLETED | FF/VI 100/25 µg QD | 0 | |
| 2 Week Run-in Period | NOT COMPLETED | VI 25 µg QD | 0 | |
| 12 Week (Wk) Treatment Period (TP) | STARTED | Placebo Run-In | 0 | |
| 12 Week (Wk) Treatment Period (TP) | STARTED | FF/VI 100/25 µg QD | 806 | |
| 12 Week (Wk) Treatment Period (TP) | STARTED | VI 25 µg QD | 814 | |
| 12 Week (Wk) Treatment Period (TP) | Completed the Treatment(Trt) Period | Placebo Run-In | 0 | |
| 12 Week (Wk) Treatment Period (TP) | Completed the Treatment(Trt) Period | FF/VI 100/25 µg QD | 764 | |
| 12 Week (Wk) Treatment Period (TP) | Completed the Treatment(Trt) Period | VI 25 µg QD | 754 | |
| 12 Week (Wk) Treatment Period (TP) | COMPLETED | Placebo Run-In | 0 | |
| 12 Week (Wk) Treatment Period (TP) | COMPLETED | FF/VI 100/25 µg QD | 764 | |
| 12 Week (Wk) Treatment Period (TP) | COMPLETED | VI 25 µg QD | 756 | |
| 12 Week (Wk) Treatment Period (TP) | NOT COMPLETED | Placebo Run-In | 0 | |
| 12 Week (Wk) Treatment Period (TP) | NOT COMPLETED | FF/VI 100/25 µg QD | 42 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02105974/flow